{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:36:34Z","timestamp":1793331394350,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009540","name":"Frank A. Campini Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.coph.2021.08.013","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T01:39:48Z","timestamp":1632274788000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"special_numbering":"C","title":["Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus"],"prefix":"10.1016","volume":"61","author":[{"given":"John P.","family":"Kane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive R.","family":"Pullinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7111-2059","authenticated-orcid":false,"given":"Ira D.","family":"Goldfine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Malloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2021.08.013_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3005","article-title":"Pathophysiology-based phenotyping in type 2 diabetes: a clinical classification tool","volume":"34","author":"Stidsen","year":"2018","journal-title":"Diab Metab Res Rev"},{"key":"10.1016\/j.coph.2021.08.013_sref2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2021.08.013_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1515\/jpem-2014-0384","article-title":"Maturity-onset diabetes of the young (MODY): an update","volume":"28","author":"An\u0131k","year":"2015","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.coph.2021.08.013_bib4","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1002\/jcp.30200","article-title":"Circular RNAs: rising stars in lipid metabolism and lipid disorders","volume":"236","author":"Yu","year":"2021","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.coph.2021.08.013_bib5","doi-asserted-by":"crossref","DOI":"10.23736\/S0391-1977.20.03273-3","article-title":"The triglyceride glucose index (TyG) and CDKAL1 gene rs10946398 SNP are associated with NAFLD in Chinese adults","author":"Zhu","year":"2020","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.coph.2021.08.013_sref6","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2021.08.013_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0741-5214(89)90222-X","article-title":"Particle size distribution of lipoproteins from human atherosclerotic plaque: a preliminary report","volume":"9","author":"Rapp","year":"1989","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.coph.2021.08.013_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2021.08.013_bib9","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.coph.2021.08.013_bib10","doi-asserted-by":"crossref","first-page":"5245308","DOI":"10.1155\/2020\/5245308","article-title":"Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis","volume":"2020","author":"Khatana","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.coph.2021.08.013_sref11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcjd.2019.07.003","article-title":"Dyslipidemia management in adults with diabetes","volume":"44","author":"Lazarte","year":"2020","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.coph.2021.08.013_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MOL.0000000000000710","article-title":"Hypertriglyceridemia: new approaches in management and treatment","volume":"31","author":"Wolska","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.coph.2021.08.013_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/CIRCULATIONAHA.119.044440","article-title":"REDUCE-IT USA: results from the 3146 patients randomized in the United States","volume":"141","author":"Bhatt","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2021.08.013_bib14","doi-asserted-by":"crossref","first-page":"173114","DOI":"10.1016\/j.ejphar.2020.173114","article-title":"Statins and PCSK9 inhibitors: a new lipid-lowering therapy","volume":"878","author":"Gallego-Colon","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2021.08.013_bib15","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2019.11.072","article-title":"Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar","volume":"75","author":"Preiss","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.coph.2021.08.013_bib16","article-title":"Efficacy and safety of bempedoic acid in patients with hypercholesterolemia: systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Di Minno","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.coph.2021.08.013_bib17","doi-asserted-by":"crossref","first-page":"107904","DOI":"10.1016\/j.jdiacomp.2021.107904","article-title":"Multifactorial treatment of diabetic patients with cardiovascular disease to maximize results","volume":"35","author":"Athyros","year":"2021","journal-title":"J\u00a0Diabet Complicat"},{"key":"10.1016\/j.coph.2021.08.013_bib18","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1111\/bph.13805","article-title":"Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials","volume":"174","author":"Catapano","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2021.08.013_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2021.08.013_bib20","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0050078","article-title":"Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review","volume":"5","author":"Danesh","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.coph.2021.08.013_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.coph.2021.08.013_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13040-021-00260-z","article-title":"Machine learning and statistical approaches for classification of risk of coronary artery disease using plasma cytokines","volume":"14","author":"Saharan","year":"2021","journal-title":"BioData Min"},{"key":"10.1016\/j.coph.2021.08.013_bib23","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1172\/JCI127308","article-title":"Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes","volume":"129","author":"Kanter","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2021.08.013_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00125-019-4847-8","article-title":"Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis","volume":"62","author":"Aroner","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.coph.2021.08.013_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MOL.0000000000000372","article-title":"Apolipoprotein CIII is a new player in diabetes","volume":"28","author":"Juntti-Berggren","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.coph.2021.08.013_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1194\/jlr.M400304-JLR200","article-title":"Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL","volume":"46","author":"Albert","year":"2005","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.coph.2021.08.013_bib27","first-page":"5991","article-title":"Fatty acid-binding protein 4 and risk of type 2 diabetes, myocardial infarction, and stroke: a prospective cohort study","volume":"104","author":"Aleksandrova","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2021.08.013_bib28","doi-asserted-by":"crossref","first-page":"102912","DOI":"10.1016\/j.ebiom.2020.102912","article-title":"Obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance","volume":"59","author":"Arcidiacono","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2021.08.013_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.coph.2021.08.013_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2018.07.001","article-title":"Long noncoding RNAs: advances in lipid metabolism","volume":"87","author":"Zeng","year":"2018","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.coph.2021.08.013_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1210\/er.2010-0020","article-title":"Genetic syndromes of severe insulin resistance","volume":"32","author":"Semple","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.coph.2021.08.013_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.coph.2021.08.013_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pathol.2018.11.004","article-title":"Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease","volume":"51","author":"Hussain","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.coph.2021.08.013_sref34","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"129","author":"Mann","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2021.08.013_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17446651.2020.1735360","article-title":"Diagnostic strategies and clinical management of lipodystrophy","volume":"15","author":"Foss-Freitas","year":"2020","journal-title":"Expet Rev Endocrinol Metabol"},{"key":"10.1016\/j.coph.2021.08.013_bib36","doi-asserted-by":"crossref","first-page":"104412","DOI":"10.1016\/j.yexmp.2020.104412","article-title":"The alterations of mitochondrial DNA in coronary heart disease","volume":"114","author":"Hu","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.coph.2021.08.013_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-20-0189","article-title":"Mitochondrial diabetes and mitochondrial DNA mutation load in MELAS syndrome","volume":"183","author":"Chae","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.coph.2021.08.013_sref38","doi-asserted-by":"crossref","first-page":"165838","DOI":"10.1016\/j.bbadis.2020.165838","article-title":"Mitochondrial dysfunction in metabolic syndrome","volume":"1866","author":"Prasun","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.coph.2021.08.013_bib39","doi-asserted-by":"crossref","first-page":"7a","DOI":"10.1016\/0002-9149(90)90562-F","article-title":"High-density lipoprotein, low-density lipoprotein and coronary artery disease","volume":"66","author":"Wilson","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.coph.2021.08.013_bib40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cca.2010.03.023","article-title":"HDL in humans with cardiovascular disease exhibits a proteomic signature","volume":"411","author":"Vaisar","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.coph.2021.08.013_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14789450.2018.1402680","article-title":"Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?","volume":"15","author":"Shao","year":"2018","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.coph.2021.08.013_bib42","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1172\/JCI114765","article-title":"Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice","volume":"86","author":"Harris","year":"1990","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2021.08.013_bib43","first-page":"491","article-title":"Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins","volume":"88","author":"Myers","year":"1976","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.coph.2021.08.013_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/oxfordjournals.aje.a113414","article-title":"Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables","volume":"116","author":"Phillips","year":"1982","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coph.2021.08.013_bib45","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0022-2275(20)33304-6","article-title":"Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender","volume":"39","author":"O'Connor","year":"1998","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.coph.2021.08.013_sref46","article-title":"Levels of prebeta-1 high-density lipoprotein are a strong independent positive risk factor for coronary heart disease and myocardial infarction: a meta-analysis","volume":"10","author":"Pullinger","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.coph.2021.08.013_bib47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.metabol.2010.01.029","article-title":"Effect of niacin on pre\u03b2-1 high-density lipoprotein levels in diabetes","volume":"60","author":"Pan","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.coph.2021.08.013_bib48","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacl.2017.04.118","article-title":"Moderate statin treatment reduces prebeta-1 high-density lipoprotein levels in dyslipidemic patients","volume":"11","author":"Quinn","year":"2017","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.coph.2021.08.013_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcsm.12654","article-title":"Effects of statins on mitochondrial pathways","volume":"12","author":"Mollazadeh","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.coph.2021.08.013_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0b013e328329233b","article-title":"Remaley AT: Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease","volume":"16","author":"Rousset","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.coph.2021.08.013_bib51","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.coph.2021.08.013_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2796.2009.02095.x","article-title":"Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects","volume":"266","author":"Plomgaard","year":"2009","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.coph.2021.08.013_sref53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2337\/db19-0811","article-title":"Protection against insulin resistance by apolipoprotein M\/Sphingosine-1-Phosphate","volume":"69","author":"Kurano","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2021.08.013_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","author":"Choi","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2021.08.013_bib55","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/cells9071682","article-title":"Sphingosine-1-Phosphate metabolism in the regulation of obesity\/type 2 diabetes","volume":"9","author":"Guitton","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.coph.2021.08.013_bib56","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5551\/jat.55699","article-title":"Glycation of HDL polymerizes apolipoprotein M and attenuates its capacity to bind to sphingosine 1-phosphate","volume":"28","author":"Kobayashi","year":"2021","journal-title":"J\u00a0Atherosclerosis Thromb"},{"key":"10.1016\/j.coph.2021.08.013_bib57","doi-asserted-by":"crossref","first-page":"105730","DOI":"10.1016\/j.jsbmb.2020.105730","article-title":"Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction","volume":"202","author":"Maharaj","year":"2020","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.coph.2021.08.013_bib58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MOL.0000000000000654","article-title":"New connections with diet, adipose tissue and metabolic syndrome","volume":"31","author":"Tavernier","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.coph.2021.08.013_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/joim.12981","article-title":"Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities","volume":"287","author":"Vuorio","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.coph.2021.08.013_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4239\/wjd.v5.i2.128","article-title":"Recent advances in the molecular genetics of type 2 diabetes mellitus","volume":"5","author":"Brunetti","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.coph.2021.08.013_bib61","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.2011.207","article-title":"Functional variants of the HMGA1 gene and type 2 diabetes mellitus","volume":"305","author":"Chiefari","year":"2011","journal-title":"Jama"},{"key":"10.1016\/j.coph.2021.08.013_bib62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2021.08.013_bib63","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1086\/491674","article-title":"Identification of four gene variants associated with myocardial infarction","volume":"77","author":"Shiffman","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coph.2021.08.013_bib64","doi-asserted-by":"crossref","first-page":"e2895","DOI":"10.1371\/journal.pone.0002895","article-title":"Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction","volume":"3","author":"Shiffman","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.coph.2021.08.013_bib65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/ATVBAHA.107.153981","article-title":"Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study","volume":"28","author":"Shiffman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922100134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922100134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:55:23Z","timestamp":1761461723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148922100134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":65,"alternative-id":["S147148922100134X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2021.08.013","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2021.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}